Trial intelligence / Profile preview

Rivastigmine versus placebo for manic episodes in bipolar disorder

IRCT201704289014N161Phase 2Completed

Sponsor

Hamadan University of Medical Sciences

Start

May 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1